0001179110-17-002157.txt : 20170210
0001179110-17-002157.hdr.sgml : 20170210
20170210160442
ACCESSION NUMBER: 0001179110-17-002157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170209
FILED AS OF DATE: 20170210
DATE AS OF CHANGE: 20170210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Milne Jill C.
CENTRAL INDEX KEY: 0001644246
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 17593201
MAIL ADDRESS:
STREET 1: C/O CATABASIS PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQ., BLDG. 1400E, STE.B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2017-02-09
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001644246
Milne Jill C.
C/O CATABASIS PHARMACEUTICALS, INC.
ONE KENDALL SQ, BLDG 1400E, STE B14202
CAMBRIDGE
MA
02139
1
1
0
0
CEO and President
Stock Option (right to buy)
1.24
2017-02-09
4
A
0
200000
0
A
2027-02-08
Common Stock
200000
200000
D
This option was granted on February 9, 2017 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 9, 2017 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
/s/ Jill C. Milne
2017-02-10